Azemiopsin, a Selective Peptide Antagonist of Muscle Nicotinic Acetylcholine Receptor: Preclinical Evaluation as a Local Muscle Relaxant.
作者:
关键词
Investigation of the preclinical profile of azemiopsin demonstrated its high affinity and specificity for muscle type nicotinic acetylcholine receptor as well as good muscle relaxant capacity. Toxicology studies in mice indicated that azemiopsin was well tolerated during chronic dosing and showed no immunotoxicity, allergenic or mutagenic activity, which made it a good candidate for application as a local muscle relaxant.Key Contributionazemiopsinmyorelaxantnicotinic acetylcholine receptorpharmacokineticspreclinical studiestoxicity
主题词
动物(Animals);CHO细胞(CHO Cells);细胞系, 肿瘤(Cell Line, Tumor);仓鼠属(Cricetulus);女(雌)性(Female);人类(Humans);男(雄)性(Male);小鼠, 近交ICR(Mice, Inbred ICR);神经肌肉药(Neuromuscular Agents);烟碱拮抗剂(Nicotinic Antagonists);卵母细胞(Oocytes);肽类(Peptides);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);受体, 烟碱(Receptors, Nicotinic);毒性试验(Toxicity Tests);蝰蛇毒液类(Viper Venoms);爪蟾属(Xenopus)
DOI
10.3390/toxins10010034
PMID
29316656
发布时间
2023-09-26
- 浏览65
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文